Latest News About Lantern expands AI-enabled growth through RADR expansion

Updated 2026-06-18 00:09

The Lantern is described as an AI-driven revenue tool aimed at accelerating revenue workflows, with claims of 28% faster deal velocity and automated outreach. The Champion Agent monitors personnel shifts across the customer base to automate outreach for certain teams. In pharma, Lantern Pharma reports 2026 progress, cutting R&D spend by 47% while advancing multiple clinical programs, launching a multi-agent AI platform with Zeta.ai and expanding an AI Center of Excellence in India to scale RADR. These items illustrate Lantern's expansion into AI-powered drug discovery partnerships, supported by ongoing financing to fuel expansion.

Sources

news

news

www.newswire.ca